Unknown

Dataset Information

0

Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer.


ABSTRACT: Androgen receptor (AR) and its splice variants (AR-SVs) promote prostate cancer (PCa) growth by orchestrating transcriptional reprogramming. Mechanisms by which the low complexity and intrinsically disordered primary transactivation domain (AF-1) of AR and AR-SVs regulate transcriptional programming in PCa remains poorly defined. Using omics, live and fixed fluorescent microscopy of cells, and purified AF-1 and AR-V7 recombinant proteins we show here that AF-1 and the AR-V7 splice variant form molecular condensates by liquid-liquid phase separation (LLPS) that exhibit disorder characteristics such as rapid intracellular mobility, coactivator interaction, and euchromatin induction. The LLPS and other disorder characteristics were reversed by a class of small-molecule-selective AR-irreversible covalent antagonists (SARICA) represented herein by UT-143 that covalently and selectively bind to C406 and C327 in the AF-1 region. Interfering with LLPS formation with UT-143 or mutagenesis resulted in chromatin condensation and dissociation of AR-V7 interactome, all culminating in a transcriptionally incompetent complex. Biochemical studies suggest that C327 and C406 in the AF-1 region are critical for condensate formation, AR-V7 function, and UT-143's irreversible AR inhibition. Therapeutically, UT-143 possesses drug-like pharmacokinetics and metabolism properties and inhibits PCa cell proliferation and tumor growth. Our work provides critical information suggesting that clinically important AR-V7 forms transcriptionally competent molecular condensates and covalently engaging C327 and C406 in AF-1, dissolves the condensates, and inhibits its function. The work also identifies a library of AF-1-binding AR and AR-SV-selective covalent inhibitors for the treatment of PCa.

SUBMITTER: Thiyagarajan T 

PROVIDER: S-EPMC9910435 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer.

Thiyagarajan Thirumagal T   Ponnusamy Suriyan S   Hwang Dong-Jin DJ   He Yali Y   Asemota Sarah S   Young Kirsten L KL   Johnson Daniel L DL   Bocharova Vera V   Zhou Weidong W   Jain Abhinav K AK   Petricoin Emanuel F EF   Yin Zheng Z   Pfeffer Lawrence M LM   Miller Duane D DD   Narayanan Ramesh R  

Proceedings of the National Academy of Sciences of the United States of America 20221228 1


Androgen receptor (AR) and its splice variants (AR-SVs) promote prostate cancer (PCa) growth by orchestrating transcriptional reprogramming. Mechanisms by which the low complexity and intrinsically disordered primary transactivation domain (AF-1) of AR and AR-SVs regulate transcriptional programming in PCa remains poorly defined. Using omics, live and fixed fluorescent microscopy of cells, and purified AF-1 and AR-V7 recombinant proteins we show here that AF-1 and the AR-V7 splice variant form m  ...[more]

Similar Datasets

2022-12-31 | GSE215335 | GEO
| PRJNA889781 | ENA
| S-EPMC5890913 | biostudies-literature
| S-EPMC4022291 | biostudies-literature
| S-EPMC4012562 | biostudies-literature
| S-EPMC11599078 | biostudies-literature
| S-EPMC5392349 | biostudies-literature
| S-EPMC4308035 | biostudies-literature
| S-EPMC4975933 | biostudies-literature
| S-EPMC5907780 | biostudies-literature